The market for botanical ingredients across various industries is expected to grow significantly by 2032, with an estimated value of around $331.9 billion.
However, these products are plagued by issues related to the supply and quality of raw materials, which are often obtained by exploiting natural resources, resulting in a significant environmental footprint.
Botanical Solution Inc (BSI) has developed a proprietary technology that enables the sustainable and scalable supply of key botanical products, with none of the problems associated with the current production of traditional botanical raw materials and active ingredients.
A unique and patented R&D platform, based on plant tissue culture, allows BSI to discover and develop botanical products that are sustainable, highly consistent and cost effective. This technology eliminates major barriers such as supply and quality issues that have prevented many traditional botanicals from achieving commercial success.
BSI has developed a proprietary method of producing advanced botanical materials (ABM) from an exotic and protected tree native to Chile, Quillaja saponaria. This product serves as the active ingredient in the creation of both the biofungicide Quillibrium® and the Gold Standard vaccine adjuvant, QS-21.
Award winning Quillibrium® is a broad spectrum biofungicide that effectively prevents and controls various pathogens including Botrytis cinerea, Altenaria alternata, Sour Rot, Powdery Mildew and more. These pathogens are responsible for the loss of hundreds of millions of dollars in high-value crops worldwide.
While awaiting EPA approval for US and global distribution, the product has been successfully commercialized in Chile under the trade name BotriStop® through a partnership between BSI and Syngenta.
QS-21 is a “Gold Standard vaccine adjuvant” that is used in RSV, shingles, malaria and other vaccines, including several COVID-19 vaccine candidates.
QS-21 was originally extracted from the bark of the Quillaja saponaria. This native Chilean tree’s exploitation is strictly controlled by local authorities, leading to soaring costs and supply issues.
BSI solves the critical supply problem by growing its own trees, extracting the advanced botanical material in vitro, and providing a nearly unlimited amount of this valuable, highly demanded compound.
